Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | MTOR | P42345 | 2/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | TP53 | P04637 | 2/20 | 0.62 |
| ▸ | THRB | P10828 | 1/20 | 0.62 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.62 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.62 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.62 |
| ▸ | GMNN | O75496 | 1/20 | 0.62 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.62 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.62 |
| ▸ | THPO | P40225 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 1/20 | 0.62 |
| ▸ | RAB9A | P51151 | 1/20 | 0.62 |
| ▸ | BLM | P54132 | 1/20 | 0.62 |
| ▸ | HBB | P68871 | 1/20 | 0.62 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | CDA | P32320 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL41572 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL18512948 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL2579580 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL14441083 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL6297856 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL5953706 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL14929291 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL5697581 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL5953287 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB | |
| SCHEMBL15630246 | 1.00 | LMNA (0.62) | LMNAMTORALDH1A1TP53THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6250 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146286-A1 | SMALL RNA-BASED PROGNOSTIC SIGNATURES AND THERAPEUTIC COMPOSITIONS FOR IDIOPATHIC PULMONARY FIBROSIS | GATEHOUSE BIO INC. (US) | 2026-05-28 | — | — | US | claimed |
| US-12637673-B2 | Compositions and methods for splicing modulation OF UNC13A | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2026-05-26 | — | — | US | claimed |
| WO-2026102302-A1 | POLYNUCLEOTIDES CONTAINING A MODIFIED 3'-REGION | MODERNATX, INC. (US) | 2026-05-15 | — | — | WO | claimed |
| US-12618064-B2 | Acetylated ribonucleic acids and uses thereof | HELIX NANOTECHNOLOGIES INC (US) | 2026-05-05 | — | — | US | claimed |
| WO-2026088038-A1 | IL-17C BASED THERAPEUTICS FOR PROMOTING EPITHELIAL HEALING AND INHIBITING FIBROSIS IN OCULAR DISORDERS | DR SHROFFS CHARITY EYE HOSPITAL (IN) | 2026-04-30 | — | — | WO | claimed |
| US-20260112451-A1 | METHODS FOR GENE TRAINING | MENDAGENE LLC (US) | 2026-04-23 | — | — | US | claimed |
| US-12594295-B2 | CFTR mRNA compositions and related methods and uses | TRANSLATE BIO, INC. (US) | 2026-04-07 | — | — | US | claimed |
| EP-4711452-A2 | KLOTHO MRNA | ADvantage Therapeutics, Inc. (US) | 2026-03-18 | — | — | EP | claimed |
| CN-121574979-A | RNA for in vivo generation of tol-APCs, and preparation method and application thereof | 中国科学技术大学 | 2026-02-27 | — | — | CN | claimed |
| EP-4673547-A2 | ANTISENSE OLIGONUCLEOTIDE AGENTS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP3/NLRP1 EXPRESSION OR ACTIVATION | Molecular Axiom, Llc (US) | 2026-01-07 | — | — | EP | claimed |
| EP-0983290-A1 | METHOD FOR PRODUCING POLYMERS HAVING NUCLEO-BASES AS SIDE-GROUPS | Morphochem AG (DE) | 2000-03-08 | — | — | EP | claimed |
| WO-2000004141-A2 | USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS | RIBOZYME PHARMACEUTICALS, INC. (US) | 2000-01-27 | — | — | WO | claimed |
| WO-1999065502-A1 | OLIGONUCLEOTIDES FOR ENHANCED MODULATION OF PROTEIN KINASE C EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-23 | — | — | WO | claimed |
| WO-1999063114-A1 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN THYMIDYLATE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1999-12-09 | — | — | WO | claimed |
| WO-1999054459-A2 | NUCLEIC ACID MOLECULES WITH NOVEL CHEMICAL COMPOSITIONS CAPABLE OF MODULATING GENE EXPRESSION | RIBOZYME PHARMACEUTICALS, INC. (US) | 1999-10-28 | — | — | WO | claimed |
| WO-1999049065-A1 | ANTISENSE MODULATION OF HUMAN MDM2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 1999-09-30 | — | — | WO | claimed |
| WO-1998051697-A2 | METHOD FOR PRODUCING POLYMERS HAVING NUCLEO-BASES AS SIDE-GROUPS | MORPHOCHEM AG (DE) | 1998-11-19 | — | — | WO | claimed |
| WO-1998045472-A1 | METHOD FOR SCREENING INHIBITORS OF A DEAMINATION ENZYME ACTIVITY | HAROSH ITZIK (FR) | 1998-10-15 | — | — | WO | claimed |
| EP-0770144-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1997-05-02 | — | — | EP | claimed |
| WO-1996003526-A1 | NUCLEIC ACID AMPLIFICATION METHOD USING A MODIFIED NUCLEOSIDE, AND DETECTION OF THE AMPLIFICATION PRODUCT USING ANTIBODIES | PARTEUROP DEVELOPPEMENT (FR) | 1996-02-08 | — | — | WO | claimed |